Immunohistochemistry-Based Molecular Profiling of Muscle-Invasive Bladder Cancer: Analysis of 100 Consecutive Cases with Morphological Correlation
Medical Sciences · 2025
DOI: 10.3390/medsci13030202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, 2025. Verfasst von Elitsa Kraevska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathoanatomy, Faculty of Medicine, Medical University-Pleven, 5800 Pleven, Bulgaria. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Urinary Bladder, Biomarkers, Tumor, Carcinoma, Transitional Cell. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University Pleven, European Union - NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, Medical University—Pleven, Bulgaria.
Abstract (Originalsprache)
Background/Objectives: This study aimed to profile the molecular variants of muscle-invasive bladder cancer (MIBC) based on immunohistochemical analysis and to make a correlation with morphological characteristics in a series of 100 consecutive patients.
Methods
A retrospective single-center study was conducted on 100 consecutive cases of MIBC (2021–2024). A selected immunohistochemical (IHC) panel (including CK5/6, CK20, and p16) was applied in all cases to classify the tumors into known molecular variants (luminal papillary, luminal non-specified, luminal unstable, stroma-rich, basal/squamous, neuroendocrine-like).
Results
Seven molecular subtypes are identified: basal (33%), luminal papillary (24%), luminal unstable (16%), luminal non-specified (10%), basoluminal (double-positive) (9%), neuroendocrine-like (double-negative with neuroendocrine morphology) (6%), and stroma-rich (2%). This distribution largely matches published data (Consensus Classification and The Cancer Genome Atlas (TCGA)), with minor differences (e.g., a lower share of the stroma-rich variant). A strong correlation is found between the histological subtypes of some tumors and their molecular variant (χ2, p < 0.001): for example, all cases of urothelial carcinoma with squamous differentiation are basal, micropapillary tumors are entirely luminal, and small-cell carcinomas are neuroendocrine-like.
Conclusions
The results demonstrate that the morphological subtype of urothelial carcinoma largely predetermines the molecular profile. Combining classic histopathology with IHC-based profiling allows for a more complete characterization of the tumor and aids prognosis and personalized treatment in MIBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathoanatomy, Faculty of Medicine, Medical University-Pleven, 5800 Pleven, Bulgaria.
ORCID-Profile: Elitsa Kraevska
Förderung
- Medical University Pleven
- European Union - NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria
- Medical University—Pleven, Bulgaria
- European Union—NextGenerationEU
Zitieren
APA
Kraevska, E., & Popovska, S. (2025). Immunohistochemistry-Based Molecular Profiling of Muscle-Invasive Bladder Cancer: Analysis of 100 Consecutive Cases with Morphological Correlation. Medical Sciences. https://doi.org/10.3390/medsci13030202
Vancouver
Kraevska E, Popovska S. Immunohistochemistry-Based Molecular Profiling of Muscle-Invasive Bladder Cancer: Analysis of 100 Consecutive Cases with Morphological Correlation. Medical Sciences. 2025. doi:10.3390/medsci13030202
BibTeX
@article{Kraevska2025,
author = {Kraevska, Elitsa and Popovska, Savelina},
title = {Immunohistochemistry-Based Molecular Profiling of Muscle-Invasive Bladder Cancer: Analysis of 100 Consecutive Cases with Morphological Correlation},
journal = {Medical Sciences},
year = {2025},
doi = {10.3390/medsci13030202}
}
EUVIMED